Navigation Links
Rubella nearly wiped out

Rubella, or German measles, a disease that once infected tens of thousands of people a year and was responsible for numerous birth defects, is on the verge of being eliminated in the United States. Cases of rubella have fallen from almost 58,000 in 1969//, the year the vaccine was introduced, to 272 in 1999.

Rubella, which typically causes a mild rash, was considered harmless until the 1940s, when it was discovered that it could cause birth defects in children whose mothers were infected while pregnant. The virus can cause miscarriages and stillbirths, as well as problems for babies including cataracts, heart defects, hearing damage and developmental delays.

The goal now should be to educate foreign-born people about rubella, ensure that doctors ask patients about vaccinations, and perhaps help other countries with their vaccination programs.

Infants in the United States are routinely immunized against rubella. And in the late 1970s, doctors also began vaccinating women of childbearing age. In 1989, the United States set a goal of eliminating rubella by 2000. From 1992 through 1997, fewer than 300 cases were reported annually, with an all-time low of 128 cases in 1995. As of January 2001, 44 of 47 countries in the Americas had childhood rubella vaccination programs, though most have been in effect for less than three years.
'"/>




Page: 1

Related medicine news :

1. Rubella- a Thing of the Past in US
2. Rubella Outbreak Grips Vietnam
3. Cancer drugs in development nearly doubled since 1995
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Rubella nearly wiped out

(Date:2/28/2015)... 2015 Heart diseases are on the ... of urban adult population and 5 percent of rural ... and 20-30 percent of them require specialized investigation and ... coronary vascular diseases (CVD). , A division of Indian ... research report titled “Indian Coronary Stent Market Forecast to ...
(Date:2/28/2015)... With their commitment to achieving physical ... additional exercise to their already robust library of oblique ... commonly known as, is often performed on a stationary ... in a relatively safe manner and can be performed ... full description of “Rope Pulls” is located in the ...
(Date:2/28/2015)... 28, 2015 March—also known as ... to remind ourselves and others that suspected head ... NeuroSurgical Specialists (ANS). , Concussions are a form ... 75% of TBIs. There are 1.6-3.8 million sports-related ... benign, but it is a brain injury. Many ...
(Date:2/28/2015)... (PRWEB) February 28, 2015 Indosoft ... software suite for Asterisk, are pleased to announce the ... successful 5.7 and 5.8 versions of Q-Suite, this new ... as a number of new features to the leading ... 2015. , Q-Suite 5.9 will add features to enhance ...
(Date:2/28/2015)... MD (PRWEB) February 28, 2015 The ... present its annual awards at the International Symposium on ... will be held at the Hyatt Regency Bethesda in ... for their dedicated work and commitment to the mission ... the Year Award will be presented to Miriam Ratner. ...
Breaking Medicine News(10 mins):Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 2Health News:Atlantic NeuroSurgical Specialists (ANS) Focus on National Brain Injury Awareness Month to Educate the General Public on Head Trauma 3Health News:Indosoft Proudly Announces Q-Suite 5.9 Call Center Software for Asterisk 2Health News:Cancer Research Foundation Honors Award Recipients 2Health News:Cancer Research Foundation Honors Award Recipients 3Health News:Cancer Research Foundation Honors Award Recipients 4
... HealthDay Reporter , FRIDAY, Aug. 13 (HealthDay News) ... acetaminophen, best known as Tylenol, were more than twice ... take the over-the-counter pain and fever reducer, new research ... increased chance of eczema and rhinoconjunctivitis, or allergic nasal ...
... to adopt electronic medical records helps speed adoption by ... in the current issue of Management Science , ... and the Management Sciences (INFORMS)., "Social Contagion and Information ... U.S. Hospitals" is by Corey M. Angst and Ken ...
... Institute for Environmental Education and Research is helping ... local workers to create a pool of green ... and energy efficiency. A handful of local ... a U.S. Labor Department Energy Training Partnership grant, ...
... of Medicine today announced that the National Institutes of ... of Food Allergy Research (CoFAR), providing an additional $29.9 ... of food allergy. Mount Sinai is the primary research ... country. Under the renewed grant, Mount Sinai researchers ...
... Glioblastoma multiforme is the most common form of brain cancer; ... on diagnosis, the chances of survival of the patient is ... known nor the manner to prevent it. What is more, ... in 40 years, unlike other cancers such as, for example, ...
... LOS ANGELES (Aug. 11, 2010) Understanding the underlying genetic weakness ... and provide the key to effective treatment, a new study ... an investigational drug, Olaparib, can reduce the size of tumors ... mutations. The Phase II ovarian cancer ...
Cached Medicine News:Health News:Tylenol Use Linked to Asthma, Other Allergies in Teens 2Health News:Tylenol Use Linked to Asthma, Other Allergies in Teens 3Health News:Tylenol Use Linked to Asthma, Other Allergies in Teens 4Health News:Speed electronic medical record adoption via key medical centers, says Management Science 2Health News:Carnegie Mellon's Steinbrenner Institute helps grow green jobs 2Health News:Mount Sinai leads Consortium of Food Allergy Research with $29.9 million grant 2Health News:Multidisciplinary treatment of glioblastoma multiforme can extend patient's life 2Health News:New drug reduces tumor size in women with advanced hereditary ovarian or breast cancer 2
(Date:2/27/2015)... and HOUSTON, TX , ... the "Company") (TSX-V: EPI) and Bloom Burton & Co. ... from voluntary contractual lock-up (the "Lock-Up") 2,353,130 common shares ... Common Shares originally subject to the Lock-Up. Of the ... be free trading immediately upon release from the Lock-Up ...
(Date:2/27/2015)... , Feb. 27, 2015  Boston Scientific Corporation ... in the Barclays 2015 Annual Healthcare Conference on March ... Dan Brennan , executive vice president and ... president, Investor Relations, will participate in a 25-minute question ... analyst at approximately 1:05 p.m. ET. Following a 5-minute ...
(Date:2/27/2015)... 2015   Synageva BioPharma Corp. (Synageva) ... developing therapeutic products for rare diseases, joins the ... Organisation for Rare Diseases™ (EURORDIS™), The Global Genes ... Rare Disease Day. On the last ... and other participants conduct special events to raise ...
Breaking Medicine Technology:ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6
... N.C., Dec. 21, 2010 Charlotte Business Journal ... an affiliate of Diagnostic Devices Inc. – one of ... an awards luncheon held at the Charlotte Convention Center ... recognizes Charlotte area companies for their leadership, entrepreneurial excellence, ...
... 21, 2010 Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ... Executive Officer, will host a conference call and webcast tomorrow, ... a.m. Pacific Time) to provide an update following the completion ... Administration (FDA) for the lorcaserin New Drug Application (NDA). ...
Cached Medicine Technology:Charlotte Business Journal Honors Prodigy Diabetes Care, LLC With Fast 50 Award 2Arena Pharmaceuticals to Host Conference Call and Webcast to Provide Update Following Lorcaserin End-of-Review Meeting With FDA 2Arena Pharmaceuticals to Host Conference Call and Webcast to Provide Update Following Lorcaserin End-of-Review Meeting With FDA 3
... Self-Cath Closed System is a latex-free ... for safe, simple catheterization designed to ... infections. It includes a 100% ... new EasyOff tear tab makes it ...
... The Self-Cath family ... offers patients a variety ... self-catheterization. Each catheter ... medical grade PVC and ...
... Self-Cath family of 100% ... a variety of options ... Each catheter is made ... PVC and has smooth ...
An enzyme-linked immuno-sorbent assay for the detectionand quantitation of anti-tissue Transglutaminase in serum of patients with Celiac Disease and Dermatitis Herpetiformis....
Medicine Products: